102 results about "Embolization" patented technology

Systems and methods for the intravascular treatment of clot material within a blood vessel of a human patient are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, engaging an interventional device of a catheter system with clot material in a blood vessel and withdrawing the interventional device and the portion of the clot material through a guide catheter. In some embodiments, the catheter system can include an attachment / valve member coupled to a proximal portion of the guide catheter, and the method can include unsealing the attachment / valve member to facilitate withdrawing the interventional device through the attachment / valve member without significant retention of clot material within the attachment / valve member. The method can further include resealing and aspirating the guide catheter before advancing another interventional device to the clot material to again engage and remove clot material from the blood vessel.

A device and method for intravascular treatment of an embolism, and particularly a pulmonary embolism, is disclosed herein. One aspect of the present technology, for example, is directed toward a clot treatment device that includes a support member having a plurality of first clot engagement members and second clot engagement members positioned about the circumference of a distal portion of the support member. In an undeployed state, individual first clot engagement members can be linear and have a first length, and individual second clot engagement members can be linear and have a second length that is less than the first length. The clot engagement members can be configured to penetrate clot material along an arcuate path and hold clot material to the clot treatment device.

The invention relates to the technical field of image processing, and discloses a pulmonary embolism focus segmentation method and system based on image recognition, and a storage medium. The method comprises the following steps: extracting a multi-level blood vessel topological structure of a CTPA image through blood vessel diameter gradient analysis; modeling blood vessel density distribution by using a Weibull mixed model to obtain embolism characteristic parameters; the pixel embolism probability is estimated through variational Bayesian reasoning, and a focus distribution diagram is generated; performing multi-scale feature fusion on the lesion probability graph to obtain a segmentation boundary; and obtaining a final embolism focus segmentation result based on the vascular connectivity constraint optimization boundary. The problems that blood vessel level differentiation processing cannot be achieved, and accurate probability modeling and anatomical constraint verification are lacked are solved. The accuracy of pulmonary embolism focus segmentation is improved.

Disclosed herein are clot treatment systems including mechanical thrombectomy devices and clot treatment devices, and associated devices and methods. In some embodiments, a method of removing clot material from a blood vessel of patient includes inserting a catheter to proximate the clot material within the blood vessel while radially constraining a clot treatment device and an embolic protection device within the catheter. The method can further include moving the catheter proximally to deploy the clot treatment device at least partially distal to clot material within the blood vessel, and then moving the catheter further proximally to deploy the embolic protection device at least partially proximal to the clot material. The clot treatment device can include one or more relief features configured to release captured clot material if the force on the clot treatment device exceeds a threshold.

Disclosed herein are clot treatment systems including mechanical thrombectomy devices and clot treatment devices, and associated devices and methods. In some embodiments, a method of removing clot material from a blood vessel of patient includes inserting a catheter to proximate the clot material within the blood vessel while radially constraining a clot treatment device and an embolic protection device within the catheter. The method can further include moving the catheter proximally to deploy the clot treatment device at least partially distal to clot material within the blood vessel, and then moving the catheter further proximally to deploy the embolic protection device at least partially proximal to the clot material. The clot treatment device can include one or more relief features configured to release captured clot material if the force on the clot treatment device exceeds a threshold.

Systems and methods for the intravascular treatment of clot material within a blood vessel of a human patient are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, engaging an interventional device of a catheter system with clot material in a blood vessel and withdrawing the interventional device and the portion of the clot material through a guide catheter. In some embodiments, the catheter system can include an attachment / valve member coupled to a proximal portion of the guide catheter, and the method can include unsealing the attachment / valve member to facilitate withdrawing the interventional device through the attachment / valve member without significant retention of clot material within the attachment / valve member. The method can further include resealing and aspirating the guide catheter before advancing another interventional device to the clot material to again engage and remove clot material from the blood vessel.

Disclosed herein are clot treatment systems including mechanical thrombectomy devices and clot treatment devices, and associated devices and methods. In some embodiments, a method of removing clot material from a blood vessel of patient includes inserting a catheter to proximate the clot material within the blood vessel while radially constraining a clot treatment device and an embolic protection device within the catheter. The method can further include moving the catheter proximally to deploy the clot treatment device at least partially distal to clot material within the blood vessel, and then moving the catheter further proximally to deploy the embolic protection device at least partially proximal to the clot material. The clot treatment device can include one or more relief features configured to release captured clot material if the force on the clot treatment device exceeds a threshold.

The invention provides a thrombus removal catheter for intracavity treatment, and belongs to the technical field of medical instruments. Comprising a first guide rod and a cutter body, a guide wire is inserted into the first guide rod, the outer wall of the first guide rod is slidably sleeved with a first isolation sleeve, the outer wall of the first isolation sleeve is slidably sleeved with a second guide rod, and the supporting assembly is used for supporting blood vessels of a patient. By arranging the supporting assembly, thrombus which is separated or falls off from the inner wall of a blood vessel can be blocked and protected, the thrombus is prevented from flowing to the far-end blood vessel along with blood, and the phenomenon of far-end embolism is avoided; the supporting assembly can collect thrombus separated in the cutting process or falling off from the inner wall of a blood vessel in a unified mode, the collected thrombus is discharged out of the body of a patient, the phenomenon of far-end embolism is avoided, and it is guaranteed that the thrombus is not left in the whole thrombus removing process.

The invention provides a pulmonary artery embolism imaging method, and relates to the field of magnetic resonance imaging. According to the specific implementation scheme, an acquisition window is determined according to electrocardio data and diaphragm navigation data of an adaptive patient; according to the collection window, original frequency domain data are collected in a Cartesian filling mode; performing phase compensation on the original frequency domain data by utilizing pulmonary artery pulse vector field modeling and a dynamic compensation algorithm to obtain proportionality coefficient spatial data; and performing compressed sensing reconstruction on the proportionality coefficient spatial data to generate a three-dimensional pulmonary artery image. The scheme is used for detecting pulmonary artery embolism in the free breathing state, no contrast agent is needed, radiation is avoided, and the universality of applicable people and the inspection safety are improved. According to the technology, by reducing artifact interference and optimizing image quality and scanning efficiency, rapid and accurate diagnosis is achieved, the comfort level of a patient and clinical diagnosis efficiency are remarkably improved, and the technology has important application value and social benefits.

The invention belongs to the field of biomedical materials, and particularly relates to a coagulation-promoting embolism microsphere and a preparation method thereof. The sericin-based embolism microspheres are creatively prepared, and the sericin membrane layer on the surface of the microspheres can prevent the risk that a catheter is solidified during an operation due to thrombin burst release during the operation. On the other hand, sericin in the microspheres has excellent water absorption swelling property and lubricity, and is beneficial to embolism and prevention of reflux; moreover, sericin molecules contain a large amount of hydroxyl and carboxyl, so that the chelation of blood coagulation factor calcium ions is greatly improved. In addition, thrombin factors are loaded into the microspheres, calcium ions are chelated on the surfaces of the microspheres, the microspheres are endowed with rapid embolism capacity through the superimposed effect, blood flow blocking of target blood vessels can be effectively accelerated, and reflux is prevented. The prepared procoagulant embolism microspheres are suitable for being applied to treatment of vascular-rich tumors of the brain and can effectively prevent mistaken closure of many complex functional blood vessels of the brain due to reflux.

The invention discloses a cryoablation catheter system for pulmonary artery stent internal restenosis, and belongs to the field of medical instruments, the cryoablation catheter system comprises a catheter main body arranged on a guide wire, the catheter main body is provided with a treatment assembly, the treatment assembly is located at the far end of the catheter main body, the catheter main body is provided with a control handle, and the control handle is located at the far end of the catheter main body. The control handle is located at the near end of the catheter body, and the treatment assembly comprises a near-end balloon, a far-end balloon and a freezing balloon. When the near-end balloon and the far-end balloon are simultaneously full, a closed treatment cabin isolated from near-end blood flow and far-end blood flow can be formed in a blood vessel of a target treatment section, the freezing balloon is located in the treatment cabin, the closed treatment cabin thoroughly eliminates the blood flow hot pool effect, cold is prevented from being taken away by the blood flow, and the treatment effect is improved. Freezing energy is intensively acted on a diseased region, so that the ablation efficiency and accuracy are improved; meanwhile, thrombus, tissue debris and whole body blood flow which fall off in the treatment process are isolated, the risk of far-end embolism is reduced from the source, and damage to the blood vessel wall is avoided.

The invention discloses a coated yttria-90 loaded radioactive microsphere and a preparation method and application thereof, and relates to the technical field of radioactive microsphere preparation, and the preparation method comprises the following steps: preparing a polyvinyl alcohol microsphere by using a microfluidic technology; the preparation method comprises the following steps: labeling polyvinyl alcohol microspheres with yttrium-90 radionuclide to obtain yttrium-90 loaded radiation microspheres; and coating the polylactic acid-glycolic acid copolymer on the surface of the yttria-90 loaded radioactive microsphere to obtain the coated yttria-90 loaded radioactive microsphere. The composite radioactive microspheres with uniform particle size, stable radioactivity and controllable characteristics can be obtained, and the composite radioactive microspheres are expected to be applied to transcatheter arterial radioembolism (TARE) treatment of liver cancer.

The systems and methods of the present invention can remove target material (including blood clots) from body parts (including but not limited to the circulatory system) for the treatment of pulmonary embolism (PE), deep vein thrombosis (DVT), cerebral vascular embolism, and other vascular obstructions. The capture system may include a tubular body and an end having an opening and a capture guide. In some embodiments, the body or funnel tip of the catheter is expandable.

The present application relates to the technical field of pharmaceutical formulations and provides zedoary turmeric oil / oxidized regenerated cellulose embolization microspheres, a preparation method therefor, and use thereof. In the present application, with zedoary turmeric oil as a core solution, a mixed solution of oxidized regenerated cellulose, sodium alginate, and gelatin as a shell layer solution, and a divalent or trivalent metal salt solution as a receiving solution, the zedoary turmeric oil / oxidized regenerated cellulose embolization microspheres are prepared by means of a coaxial electrostatic spraying method. The zedoary turmeric oil / oxidized regenerated cellulose embolization microspheres prepared in the present application have a marked core-shell structure, are uniform in size and good in sphericity, can effectively hide the pungent smell of zedoary turmeric oil, improves the stability of zedoary turmeric oil, and enables directed embolization in tumor blood vessels, thereby reducing toxic and side effects. In addition, the embolization microspheres prepared in the present application have good mechanical properties; therefore, the microspheres can effectively resist deformation under compression and prevent fragmentation within the body, enabling firm embolization of zedoary turmeric oil at the tumor vascular site.

The application belongs to the technical field of biological detection, and discloses a cardiovascular marker control article and a preparation method thereof. The cardiovascular marker control article comprises a serum matrix, antigens, a preservative and a stabilizer. The antigens include cardiac troponin I antigens, creatine kinase isoenzyme antigens, myoglobin antigens, amino-terminal brain natriuretic peptide precursor antigens, brain natriuretic peptide antigens, D-dimer antigens, heart-type fatty acid-binding protein antigens, myeloperoxidase antigens and lipoprotein phospholipase A2 antigens. The stabilizer includes at least one of D-trehalose, sucrose, glycine, inositol and polyethylene glycol. The cardiovascular marker control article can cover various cardiovascular disease markers, including heart failure, pulmonary embolism, vasculitis and atherosclerosis, myocardial injury, myocardial infarction and the like. The control article can be used as a third-party control article for indoor and inter-laboratory quality control of a cardiovascular disease screening and auxiliary diagnosis measurement system.

A vacuum aspiration system may be used to treat thromboembolic disease, such as deep vein thrombosis or pulmonary embolism. The system includes a housing, and a fluid flow path extending through the housing. An aspiration catheter is in fluid communication with the flow path, and a connector is configured to place a source of aspiration in communication with the flow path. A hemostasis valve is provided in the housing. The housing may be configured to receive and releasably engage a thrombus engagement tool.

The present invention relates to the technical field of biology, and in particular to a nucleic acid targeting coagulation factor XI and a use thereof. The nucleic acid of the present invention can effectively reduce the level of coagulation factor XI and can effectively inhibit the formation of thrombi, thereby preventing and / or treating multiple diseases caused by thrombi, such as pulmonary embolism, venous embolism, deep venous embolism, myocardial infarction, and stroke.

The application discloses a method for constructing a 4D FLOW-based hemodynamic evaluation pulmonary embolism prognosis prediction model and application, relates to the medical image technology field, and comprises the following steps: collecting 4D-Flow images of patients who have been diagnosed with pulmonary embolism from medical institutions to obtain image data A; pre-processing the image data A, and dividing the pre-processed image data A into a training set and a verification set according to a proportion; respectively performing imageomic feature extraction, clinical feature extraction and 4D FLOW hemodynamic feature extraction on the training set and the verification set; screening the imageomic features and the clinical features and 4D FLOW hemodynamic detection indexes to obtain key features; and based on the key features, establishing a multi-omics prediction model for pulmonary embolism prognosis prediction, thereby providing a new imaging reference for pulmonary embolism treatment.

The invention belongs to the technical field of medicines, and particularly relates to application of penicillin tenuipes in preparation of a product for preventing or treating ischemic encephalopathy, cell experiments and animal experiments show that penicillin tenuipes has a good treatment effect on cerebral thrombosis and middle artery embolism, can obviously improve behavioral scores after ischemia, and can be used for preparing a medicine for preventing or treating ischemic encephalopathy. And cerebral thrombus and blood vessel diameter conditions. The penicillin tenuipes also has an anti-inflammatory effect. Therefore, the compound can be used for preparing medicines for preventing or treating ischemic encephalopathy.

Systems and methods for the intravascular treatment of clot material within a blood vessel of a human patient are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, engaging an interventional device of a catheter system with clot material in a blood vessel and withdrawing the interventional device and the portion of the clot material through a guide catheter. In some embodiments, the catheter system can include an attachment / valve member coupled to a proximal portion of the guide catheter, and the method can include unsealing the attachment / valve member to facilitate withdrawing the interventional device through the attachment / valve member without significant retention of clot material within the attachment / valve member. The method can further include resealing and aspirating the guide catheter before advancing another interventional device to the clot material to again engage and remove clot material from the blood vessel.

Disclosed herein are methods and compositions for enhancing an immune response to a solid tumor in a subject. In some embodiments, a method comprises: (a) administering to the subject a hypoxia-activated bioreductive agent (HABA); (b) inducing hypoxia by (i) administering a hypoxia-inducing agent to the subject or (ii) embolizing one or more blood vessels supplying the solid tumor; and (c) administering an immune checkpoint inhibitor prior to, simultaneously with, or subsequent to step (b) in an amount effective to enhance an immune response to the solid tumor, as compared to an immune response in the absence of the immune checkpoint inhibitor. Kits for use in the disclosed methods are also provided.

The present invention provides a method for identifying pulmonary embolism based on non-contrast CT, belonging to the technical field of deep learning. In order to solve the problem in the prior art that the identification of pulmonary embolism mostly relies on contrast-enhanced CT and it is impossible to quickly and accurately identify pulmonary embolism for non-contrast CT data. The method of the present invention performs pulmonary contour segmentation on non-contrast CT images through a pulmonary contour segmentation model; performs segmentation of pulmonary blood vessels in non-contrast CT through a blood vessel segmentation model; through a pulmonary embolism extraction model, uses the pulmonary embolism area on contrast-enhanced CT as the gold standard to mark the pulmonary embolism area in non-contrast CT, determines the embolism suspicious area by considering the CT value difference between pulmonary embolism and blood vessels and the vascular morphological features caused by pulmonary embolism for the pulmonary embolism in non-contrast CT, optimizes the model by minimizing the difference between the suspicious area and the gold standard, and uses the optimized model to perform pulmonary embolism segmentation on non-contrast CT. The present invention can achieve high sensitivity and accuracy in predicting pulmonary embolism based on non-contrast CT.

The invention discloses an umbrella-shaped catcher for cardiac mucinoma, which comprises a net bag, an umbrella-shaped net bag, an umbrella-shaped net bag, an umbrella-shaped net bag, an umbrella-shaped net bag and an umbrella-shaped net bag, the rubber ring is arranged along the opening, is fixedly connected with the net bag and is used for shrinking the opening through self elasticity; the two adjusters are symmetrically arranged on the two sides of the net bag and connected with the outer wall of the net bag, and each adjuster comprises a sleeve and an adjusting rod; wherein the outer wall of the sleeve is connected with the net bag, one end of the adjusting rod is connected with the net bag, the other end of the adjusting rod penetrates through the sleeve and extends to the outside, and the adjusting rod can move relative to the sleeve in the axial direction so as to be used for dynamically adjusting the size of the opening. Therefore, the difficulty of surgical operation can be reduced, and the accidental risk of postoperative visceral organ embolism caused by the fact that the broken mucus tumor is left in the heart can be avoided.

Processes are provided based on an interventional (device-based) approach to minimize the development of intramyocardial hemorrhage within the myocardial infarction (MI) zone. In one exemplary process, the revascularization occurs in an incremental fashion prior to fully opening the vessel, so as to modulate the hydrostatic pressure transmitted from the proximal end of the catheter, prior to placing a stent. In another exemplary process, the stent will be placed within the central core of the embolization and will slowly expand within the lumen reaching full patency over a period of time. Devices operated with these processes can also greatly reduce the chance of development of intramyocardial hemorrhage with the MI zone. These developments can improve the outcome in hemorrhagic patients, who otherwise carry a significant risk for heart failure and sudden death.

The invention relates to the technical field of medical image processing, and discloses a liver cancer rupture bleeding embolism treatment curative effect image evaluation method and system, and the method comprises the steps: S1, obtaining enhanced CT image data of a patient after liver cancer rupture bleeding embolism treatment, carrying out the preliminary region division of a focus region of the enhanced CT image data, and carrying out the image segmentation of the focus region; obtaining a preliminary region division result; s2, when an interaction correction mark made by a user on at least one sub-region of the preliminary region division result is received, the preliminary region division result is adjusted in real time, the boundary of the adjusted sub-region is obtained, and the interaction correction mark indicates the real organization type of the sub-region; s3, circularly executing the step S2 to perform interactive iteration correction on the boundary of the sub-region until the user confirms a final division result; and S4, performing volume quantitative evaluation on different types of tissues of the final division result, and generating an evaluation report. According to the invention, misjudgment caused by fuzzy and overlapped image features is effectively avoided.

The invention relates to the technical field of health monitoring, in particular to venous thromboembolism monitoring equipment which comprises an evaluation module used for providing an evaluation scale, collecting filling information of a patient and generating a risk level evaluation result; the behavior guidance module is used for generating corresponding guidance suggestions based on the risk level assessment result, so that the patient can be protected according to the guidance suggestions; the monitoring module is used for collecting monitoring data in the protection process of the patient according to the guidance suggestions, and the monitoring data comprise leg circumference data, pain feeling data, skin color data, body temperature data, limb swelling data and pulmonary embolism expression data; and the early warning module is used for generating early warning information based on the monitoring data, and sending the early warning information to related medical personnel, so that manual monitoring is replaced by the monitoring equipment, the self-protection consciousness of the patient can be autonomously stimulated, the monitoring effect is improved, and the morbidity of venous thromboembolism is reduced.

Methods for performing non-invasive thrombolysis with ultrasound using, in some embodiments, one or more ultrasound transducers to focus or place a high intensity ultrasound beam onto a blood clot (thrombus) or other vascular inclusion or occlusion (e.g., clot in the dialysis graft, deep vein thrombosis, superficial vein thrombosis, arterial embolus, bypass graft thrombosis or embolization, pulmonary embolus) which would be ablated (eroded, mechanically fractionated, liquefied, or dissolved) by ultrasound energy. The process can employ one or more mechanisms, such as of cavitational, sonochemical, mechanical fractionation, or thermal processes depending on the acoustic parameters selected. This general process, including the examples of application set forth herein, is henceforth referred to as “Thrombolysis.”

The present invention covers the use of chymase inhibitors in general and more in particular substituted bicyclically substituted uracils of general formula (I) as described and defined herein, and 3-methylbenzo-[b]thiophene)-2-sulfonamido derivatives of general formula (II) for manufacturing pharmaceutical compositions for the treatment or prophylaxis of stroke, pulmonary embolism, deep or superficial vein thrombosis, thrombotic microangiopathy, thrombotic microangiopathy in hypercoagulable states after infection, inflammation, transplantation, disseminated intravascular coagulation, vaccine-induced immune thrombotic thrombocytopenia, vascular access site thrombosis or occlusion.

The application provides a method and device for recommending a hepatic cancer embolism placement point planning, wherein the method comprises the following steps: obtaining input data; segmenting the input data to obtain a segmentation result of the input data, and classifying the segmentation result to determine whether there is a high-risk tumor in the liver; if there is a high-risk tumor in the liver, calculating an embolism placement point according to the segmentation result, generating an embolism placement point planning result; synthesizing the embolism placement point planning result with an original medical image to generate a recommended scheme, and outputting the recommended scheme. Through deep learning, machine learning and traditional image processing methods, various organs such as patient arterial vessels, livers, tumors and bones are automatically segmented, and according to the automatically generated segmentation information, recommended information is generated to recommend the embolism placement point of each tumor, so as to assist doctors in comprehensively and deeply understanding the condition of the patient.

The present invention relates to a solid pharmaceutical dosage form for oral administration containing (4S)-2 4 -chloro-4-ethyl-7 3 -fluoro-3 5 -methoxy-3 2 ,5-dioxo-1 4 -(trifluoromethyl)-3 2 H-6-aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-dibenzena-heptafane-7 4 -carboxamide (active ingredient (I)), characterized in that the active ingredient (I) is present in an amorphous form and is immediately released from the solid pharmaceutical dosage form for oral administration, a method for preparing the same, its use as a medicine, and its use for the treatment and / or prevention of diseases, particularly cardiovascular diseases, preferably thrombotic or thromboembolic diseases, and edema, and eye diseases. 【Chemical formula 1】 TIFF2026509613000011.tif37158